Researchers developed an exosome-based platform, “safeEXO-Cas,” that significantly enhances the delivery of CRISPR/Cas9 genome editing components to specific cells and tissues.
About SafeEXO-Cas:
- SafeEXO-Cas employs exosomes—naturally occurring vesicles renowned for their potential as drug delivery vehicles.
- This platform specializes in boosting the delivery of CRISPR/Cas9 components to targeted cells, enhancing the precision of genetic interventions.
- It plays a pivotal role in advancing precision medicine, particularly in enhancing the treatment of diseases like cancer. This ensures more accurate and targeted therapeutic interventions.
Ref: Source
| UPSC IAS Preparation Resources | |
| Current Affairs Analysis | Topperspedia |
| GS Shots | Simply Explained |
| Daily Flash Cards | Daily Quiz |